SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of the reference products.1,2 "The FDA approvals of BILDYOS and BILPREVDA mark a significant step toward expanding access to critical bone care treatments needed by millions of people in the US, inclu
- The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November 20; final awardees to be announced in August 2026- Selected researchers will receive up to USD 600,000 in research funding, along with access to Seegene's syndromic PCR assays, instruments, and software- Program aims to advance Seegene's Technology-Sharing Initiative and expand access to molecular diagnostics SEOUL, South Korea, Sept. 2, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today the launch of the 20
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related data Enhancing dementia research by integrating AI imaging solutions with real-world data platforms SEOUL, South Korea, Sept. 2, 2025 -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (I
SEOUL, South Korea, Sept. 2, 2025 -- Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans to launch its new healthcare platform, HARVEST™, this December. The platform is designed to allow medical institutions and pharmaceutical companies to collaborate on research without exposing sensitive patient data. Medical research often requires large, multi-institutional datasets, but privacy regulations and security risks have made data sharing difficult. According to IBM, the average cost of a healthcare data breach is $10.93 mill
Infosys Cobaltの力を活用してスマートで持続可能なエンターテインメント体験を可能に 神戸市、日本およびバンガロール、インド, 2025年9月2日 --– インフォシス(NSE: INFY) (BSE: INFY) (NYSE:INFY)は、次世代デジタルサービスとコンサルティングのグローバルリーダーとして、日本・神戸市の多目的アリーナ「GLION ARENA KOBE(ジーライオンアリーナ神戸)」を運営する、株式会社One Bright KOBEとの長期的な提携を本日発表します。この提携の一環として、インフォシスはGLION ARENA KOBEのオフィシャルデジタルイノベーションおよびGX(グリーン・トランスフォーメーション)パートナーとなります。日本において初めてとなるエンターテインメントアリーナとの戦略的提携は、先進的なデジタルイノベーションと持続可能な実践を通じて、ライブエンターテインメントとスポーツを革新するものです。ファンと訪問者の体験を向上させることで、業界の新たな基準を確立するだけでなく、新たな収益機会を開拓し、ライブイベントの新たな時代を築きます。この提携は、企業のクラウド移行を加速するためのサービス、ソリューション、プラットフォームのセットであるInfosys Cobaltの力を活用しています。 GL
Infosys Cobalt to power a smart and sustainable entertainment experience KOBE, Japan and BENGALURU, India, Sept. 2, 2025 -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a multi-year strategic collaboration with One Bright Kobe, which operates Glion Arena Kobe, a new multi-purpose arena in Kobe, Japan. As part of this collaboration, Infosys will be the Official Digital Innovation and GX (Green Transformation) partner of Glion Arena Kobe. This strategic engagement with Japan's first entertainment
[ 메디채널 황정호 기자 ] And Invites You To "Stay For More" in Saudi Tourism's Latest Campaign HONG KONG, Sept. 2, 2025 -- "Saudi, Welcome to Arabia" the consumer facing brand of the Saudi Tourism Authority (STA), launched its latest campaign starring Cristiano Ronaldo (CR7). Launching across key markets in China as well as India and Europe, "I Came for Football, I Stayed For More" brings to life a Saudi that offers visitors far more than the expected. Heralding the start of its extended season of high stakes sports, rousing entertainment, and breathtaking film
PHOENIX, Sept. 1, 2025 -- Today marks the official launch of FitTransformer, a revolutionary fitness brand redefining how people train at home. Combining cutting-edge engineering, space-saving design, and intelligent performance tracking, FitTransformer introduces the first modular system that transforms seamlessly between cardio and strength training—without taking up an entire room. "We created FitTransformer to eliminate the complexity, clutter, and cost of traditional gym equipment," says Sam, Founder and CEO of FitTransformer. "Whether you live in a studio o
Debut of "Man Up!" Book by SKH Urologist Challenges Health Barriers Among Men SINGAPORE, Aug. 30, 2025 -- Taking a step to shift mindsets and spark lasting change in how men approach their health, Sengkang General Hospital (SKH) held a Men's Health Public Forum themed "Be There, For the People Who Matter" at Suntec Convention Centre today. Bringing together close to 300 registered participants from all walks of life, this event reflected the hospital's deepening focus on preventive healthcare, early intervention, and empowering men with the to
TAIPEI, Aug. 28, 2025 -- Travel is more than a brief escape from everyday life—it is a journey to rediscover emotions and connections. Guided by the philosophy of "to serve as we would like to be served," Silks Hotel Group extends world-class hospitality into meaningful cultural encounters. With 14 properties across Taiwan, the Group invites international travelers to begin their cultural discovery from the hotel itself, venturing into local traditions, landscapes, and human connections that make Taiwan unique. Silks Place Tainan: Tea Ritual × City Walks&